Research map: Sepsis risk in patients with COPD and type 2 diabetes mellitus: influence of emerging antihyperglycemic therapies

Back to the article

Papers in this map

  1. Sensitivity Analysis in Observational Research: Introducing the E-Value · Tyler J. VanderWeele · 2017 · 6320 citations · Cited by this paper
  2. A clinician’s guide to managing multidrug-resistant tuberculosis in children and adolescents · 2025 · Related
  3. Introduction to the Analysis of Survival Data in the Presence of Competing Risks · Peter C. Austin · 2016 · 2674 citations · Cited by this paper
  4. A profile on inhaled treprostinil for pulmonary hypertension · 2026 · Related
  5. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease · Peter John Barnes · 2016 · 1716 citations · Cited by this paper
  6. Mycobacterium tuberculosis fluorescent and bioluminescent imaging technologies: addressing the issue of sensitivity · 2025 · Related
  7. Chronic obstructive pulmonary disease: molecular and cellularmechanisms · Peter John Barnes · 2003 · 1444 citations · Cited by this paper
  8. The promise of blue light in combating ventilator-associated pneumonia · 2025 · Related
  9. A global federated real-world data and analytics platform for research · Matvey B. Palchuk · 2023 · 829 citations · Cited by this paper
  10. Sex differences in clinical and radiographic features of nontuberculous mycobacterial pulmonary disease in a Chinese population · 2026 · Related
  11. Adverse Effects of GLP-1 Receptor Agonists · Theodosios D. Filippatos · 2014 · 556 citations · Cited by this paper
  12. Inhaled nitric oxide in therapy of pediatric and neonatal acute respiratory distress syndrome: the good, the bad and the ugly · 2025 · Related
  13. Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications · Saleh Hadi Alharbi · 2024 · 339 citations · Cited by this paper
  14. When cancer treatment affects the lungs: a clinical overview on pulmonary toxicity induced by new cancer drugs · 2026 · Related
  15. Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review · Min Su · 2023 · 321 citations · Cited by this paper
  16. What constitutes an obstructive ventilatory impairment in a pediatric population? A comparative study of five definitions by scholarly societies · 2025 · Related
  17. Infection as a comorbidity of COPD · Sanjay Sethi · 2010 · 253 citations · Cited by this paper
  18. Treatment options for children with pulmonary arterial hypertension associated with congenital heart disease · 2025 · Related
  19. Culture-Negative Severe Sepsis · Shipra Gupta · 2016 · 244 citations · Cited by this paper
  20. The role of the right ventricle in pulmonary arterial hypertension and imaging methods for non-invasive evaluation · 2025 · Related
  21. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD · Janice M. Leung · 2017 · 198 citations · Cited by this paper
  22. Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary Disease · Alberto A. Papi · 2006 · 178 citations · Cited by this paper
  23. An update on the safety of SGLT2 inhibitors · André Jacques Scheen · 2019 · 175 citations · Cited by this paper
  24. Validation and optimisation of an ICD-10-coded case definition for sepsis using administrative health data · Rachel Jolley · 2015 · 156 citations · Cited by this paper
  25. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study · Nikita Simms-Williams · 2024 · 142 citations · Cited by this paper
  26. The Regulation of Selenoproteins in Diabetes: A New Way to Treat Diabetes · Jing Liang · 2024 · 139 citations · Cited by this paper
  27. Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score) · Bin Liu · 2022 · 117 citations · Cited by this paper
  28. The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review · Wencan Li · 2024 · 104 citations · Cited by this paper
  29. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study · Peter Hanlon · 2018 · 89 citations · Cited by this paper
  30. Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease · Silvestro Ennio D’Anna · 2020 · 74 citations · Cited by this paper
  31. Narrative Review of Immunomodulatory and Anti-inflammatory Effects of Sodium-Glucose Cotransporter 2 Inhibitors: Unveiling Novel Therapeutic Frontiers · Sul A Lee · 2024 · 55 citations · Cited by this paper
  32. Comorbidities in COPD: Current and Future Treatment Challenges · Domenica Francesca Mariniello · 2024 · 53 citations · Cited by this paper
  33. Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis · Bonnie Liu · 2022 · 51 citations · Cited by this paper
  34. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD · Chih‐Cheng Lai · 2018 · 43 citations · Cited by this paper
  35. A Novel Role of Growth Differentiation Factor (GDF)-15 in Overlap with Sedentary Lifestyle and Cognitive Risk in COPD · Tsunahiko Hirano · 2020 · 39 citations · Cited by this paper
  36. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD · Yueh Lan Huang · 2017 · 38 citations · Cited by this paper
  37. Understanding the biases to sepsis surveillance and quality assurance caused by inaccurate coding in administrative health data · Daniel Schwarzkopf · 2023 · 36 citations · Cited by this paper
  38. Glucagon‐Like Peptide‐1 Receptor Agonists and Liver Outcomes in Patients With MASLD and Type 2 Diabetes · Chia‐Chih Kuo · 2025 · 35 citations · Cited by this paper
  39. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study · Cheng‐Yi Wang · 2016 · 32 citations · Cited by this paper

Source: OpenAlex (CC0)